Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [erratum in Science, Science, vol.245, issue.245, pp.1437-1066, 1989. ,
Origins of cystic fibrosis lung disease, N Engl J Med, vol.372, pp.351-362, 2015. ,
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect, The Lancet Respiratory Medicine, vol.1, issue.2, pp.158-163, 2013. ,
DOI : 10.1016/S2213-2600(12)70057-7
CFTR Function and Prospects for Therapy, Annual Review of Biochemistry, vol.77, issue.1, pp.701-726, 2008. ,
DOI : 10.1146/annurev.biochem.75.103004.142532
Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies, Osteoporosis International, vol.365, issue.Suppl 2, pp.1401-1412, 2016. ,
DOI : 10.1007/s00198-015-3343-3
URL : https://hal.archives-ouvertes.fr/inserm-01221835
Management of comorbidities in older patients with cystic fibrosis, The Lancet Respiratory Medicine, vol.1, issue.2, pp.164-174, 2013. ,
DOI : 10.1016/S2213-2600(13)70025-0
Compromised Bone Microarchitecture and Estimated Bone Strength in Young Adults With Cystic Fibrosis, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.9, pp.3399-3407, 2014. ,
DOI : 10.1210/jc.2014-1982
Guide to Bone Health and Disease in Cystic Fibrosis, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1888-1896, 2005. ,
DOI : 10.1210/jc.2004-1629
Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study, Thorax, vol.59, issue.2, pp.149-155, 2004. ,
DOI : 10.1136/thorax.2003.006726
The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis, Calcified Tissue International, vol.134, issue.1, pp.1-7, 2010. ,
DOI : 10.1007/s00223-009-9316-9
Update on Cystic Fibrosis-Related Bone Disease: A Special Focus on Children, Paediatric Respiratory Reviews, vol.10, issue.3, pp.134-142, 2009. ,
DOI : 10.1016/j.prrv.2009.05.001
Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis, Annals of Internal Medicine, vol.128, issue.3, pp.186-193, 1998. ,
DOI : 10.7326/0003-4819-128-3-199802010-00004
Cystic Fibrosis and Bone Disease: Defective Osteoblast Maturation with the F508del Mutation in Cystic Fibrosis Transmembrane Conductance Regulator, American Journal of Respiratory and Critical Care Medicine, vol.189, issue.6, pp.746-748, 2014. ,
DOI : 10.1164/rccm.201312-2144LE
URL : https://hal.archives-ouvertes.fr/inserm-00965536
A Roadmap to the Brittle Bones of Cystic Fibrosis, Journal of Osteoporosis, vol.11, issue.1, p.926045, 2010. ,
DOI : 10.1038/ncprheum0977
Update on maintaining bone health in cystic fibrosis, Current Opinion in Pulmonary Medicine, vol.12, issue.6, pp.453-458, 2006. ,
DOI : 10.1097/01.mcp.0000245708.59138.a4
Impact of cystic fibrosis on bone health, Current Opinion in Pulmonary Medicine, vol.16, issue.6, pp.616-622, 2010. ,
DOI : 10.1097/MCP.0b013e32833e2e94
Bone disease in cystic fibrosis: What's new?, Joint Bone Spine, vol.78, issue.5, pp.445-450, 2011. ,
DOI : 10.1016/j.jbspin.2010.11.015
Cystic fibrosis-related bone disease, Current Opinion in Endocrinology & Diabetes and Obesity, vol.20, issue.6, pp.547-552, 2013. ,
DOI : 10.1097/01.med.0000436191.87727.ec
Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis, Osteoporosis International, vol.100, issue.1, pp.10-1007, 2016. ,
DOI : 10.1007/s00198-015-3343-3
Low Bone Mineral Density in Young Children with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.9, pp.951-957, 2007. ,
DOI : 10.1164/rccm.200606-776OC
Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone, Journal of Cystic Fibrosis, vol.9, issue.1, pp.69-72, 2010. ,
DOI : 10.1016/j.jcf.2009.11.005
URL : https://hal.archives-ouvertes.fr/inserm-00501818
Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone, Thorax, vol.62, issue.7, pp.650-651, 2007. ,
DOI : 10.1136/thx.2006.075887
The F508del Mutation in Cystic Fibrosis Transmembrane Conductance Regulator Gene Impacts Bone Formation, The American Journal of Pathology, vol.180, issue.5, pp.2068-2075, 2012. ,
DOI : 10.1016/j.ajpath.2012.01.039
URL : https://hal.archives-ouvertes.fr/inserm-00846637
Enhanced F508del-CFTR Channel Activity Ameliorates Bone Pathology in Murine Cystic Fibrosis, The American Journal of Pathology, vol.184, issue.4, pp.1132-1141, 2014. ,
DOI : 10.1016/j.ajpath.2013.12.027
URL : https://hal.archives-ouvertes.fr/inserm-00994801
WNT signaling in bone homeostasis and disease: from human mutations to treatments, Nature Medicine, vol.28, issue.2, pp.179-192, 2013. ,
DOI : 10.1016/j.bone.2009.02.012
Minireview: The OPG/RANKL/RANK System, Endocrinology, vol.142, issue.12, pp.5050-5055, 2001. ,
DOI : 10.1210/endo.142.12.8536
Osteoclasts: What Do They Do and How Do They Do It?, The American Journal of Pathology, vol.170, issue.2, pp.427-435, 2007. ,
DOI : 10.2353/ajpath.2007.060834
Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets, Pathology - Research and Practice, vol.204, issue.10, pp.695-706, 2008. ,
DOI : 10.1016/j.prp.2008.07.002
Functions of RANKL/RANK/OPG in bone modeling and remodeling, Archives of Biochemistry and Biophysics, vol.473, issue.2, pp.139-146, 2008. ,
DOI : 10.1016/j.abb.2008.03.018
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation, Cell, vol.93, issue.2, pp.165-176, 1998. ,
DOI : 10.1016/S0092-8674(00)81569-X
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis, Journal of Cystic Fibrosis, vol.9, issue.2, pp.93-98, 2010. ,
DOI : 10.1016/j.jcf.2009.11.007
Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis, Advances in Medical Sciences, vol.58, issue.2, pp.338-343, 2013. ,
DOI : 10.2478/ams-2013-0011
Prostaglandins in bone: bad cop, good cop?, Trends in Endocrinology & Metabolism, vol.21, issue.5, pp.294-301, 2010. ,
DOI : 10.1016/j.tem.2009.12.004
Rescue of Impaired Fracture Healing in COX-2???/??? Mice via Activation of Prostaglandin E2 Receptor Subtype 4, The American Journal of Pathology, vol.175, issue.2, pp.772-785, 2009. ,
DOI : 10.2353/ajpath.2009.081099
15-Deoxy-? 12,14 -prostaglandin J 2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss, PLoS One, vol.10, p.122764, 2015. ,
Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner, International Immunopharmacology, vol.16, issue.2, pp.131-138, 2013. ,
DOI : 10.1016/j.intimp.2013.03.035
Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair, Journal of Clinical Investigation, vol.109, issue.11, pp.1405-1415, 2002. ,
DOI : 10.1172/JCI0215681
Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis, PLoS ONE, vol.7, issue.9, p.44552, 2012. ,
DOI : 10.1371/journal.pone.0044552.s001
Interactive Effect of Interleukin-6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANKL/RANK System, Annals of the New York Academy of Sciences, vol.1068, issue.1, pp.225-233, 2006. ,
DOI : 10.1172/JCI200419872
Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease, PLoS ONE, vol.349, issue.11, p.80098, 2013. ,
DOI : 10.1371/journal.pone.0080098.g005
Infection, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.6, pp.621-629, 2013. ,
DOI : 10.1164/rccm.201206-1150OC
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, Journal of Clinical Investigation, vol.103, issue.9, pp.1345-1352, 1999. ,
DOI : 10.1172/JCI5703
Bone-Immune Cell Crosstalk: Bone Diseases, Journal of Immunology Research, vol.2, issue.1, p.108451, 2015. ,
DOI : 10.1158/0008-5472.CAN-12-2202
URL : http://doi.org/10.1155/2015/108451
Fluorescent Indicator Methods to Assay Functional CFTR Expression in Cells, Methods Mol Med, vol.70, pp.187-196, 2002. ,
DOI : 10.1385/1-59259-187-6:187
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770, Proceedings of the National Academy of Sciences, vol.106, issue.44, pp.18825-18830, 2009. ,
DOI : 10.1073/pnas.0904709106
VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface, Chemistry & Biology, vol.21, issue.5, pp.666-678, 2014. ,
DOI : 10.1016/j.chembiol.2014.02.021
An unexpected effect of TNF-alpha on F508del-CFTR maturation and function, F1000Res, vol.4, p.218, 2015. ,
Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells, The International Journal of Biochemistry & Cell Biology, vol.44, issue.6 ,
DOI : 10.1016/j.biocel.2012.03.010
Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?, European Respiratory Journal, vol.45, issue.3, pp.845-848, 2015. ,
DOI : 10.1183/09031936.00174014
Severe osteopenia in CFTR-null mice, Bone, vol.35, issue.3, pp.595-603, 2004. ,
DOI : 10.1016/j.bone.2004.05.021
URL : https://hal.archives-ouvertes.fr/hal-00181103
Persistent Osteopenia in Adult Cystic Fibrosis Transmembrane Conductance Regulator???deficient Mice, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.3, pp.309-315, 2008. ,
DOI : 10.1164/rccm.200705-659OC
Murine Model for Cystic Fibrosis Bone Disease Demonstrates Osteopenia and Sex-Related Differences in Bone Formation, Pediatric Research, vol.7, issue.3, pp.311-316, 2009. ,
DOI : 10.1203/PDR.0b013e3181961e80
European cystic fibrosis bone mineralisation guidelines, Journal of Cystic Fibrosis, vol.10, issue.2, pp.16-23, 2011. ,
DOI : 10.1016/S1569-1993(11)60004-0
Anoctamin-6 Controls Bone Mineralization by Activating the Calcium Transporter NCX1, Journal of Biological Chemistry, vol.290, issue.10, pp.6270-6280, 2015. ,
DOI : 10.1074/jbc.M114.602979
Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.3, pp.306-311, 2006. ,
DOI : 10.1164/rccm.200512-1943OC
Inflammatory related changes in bone mineral content in adults with cystic fibrosis, Thorax, vol.59, issue.7, pp.613-617, 2004. ,
DOI : 10.1136/thx.2003.012047
TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression, Journal of Translational Medicine, vol.11, issue.1, p.19, 2013. ,
DOI : 10.1016/j.jcf.2011.09.006
Novel functions for NF??B: inhibition of bone formation, Nature Reviews Rheumatology, vol.276, issue.10, pp.607-611, 2011. ,
DOI : 10.1038/nrrheum.2010.133
Inhibition of osteoblastic bone formation by nuclear factor-??B, Nature Medicine, vol.12, issue.6, pp.682-689, 2009. ,
DOI : 10.1038/nm.1954
Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells., Journal of Clinical Investigation, vol.101, issue.11, pp.2598-2605, 1998. ,
DOI : 10.1172/JCI2865
Genistein Inhibits Constitutive and Inducible NF??B Activation and Decreases IL-8 Production by Human Cystic Fibrosis Bronchial Gland Cells, The American Journal of Pathology, vol.155, issue.2, pp.473-481, 1999. ,
DOI : 10.1016/S0002-9440(10)65143-7
CFTR Is a Negative Regulator of NF??B Mediated Innate Immune Response, PLoS ONE, vol.31, issue.2, p.4664, 2009. ,
DOI : 10.1371/journal.pone.0004664.s004
15-Deoxy-Delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway, Proceedings of the National Academy of Sciences, vol.97, issue.9, pp.4844-4849, 2000. ,
DOI : 10.1073/pnas.97.9.4844
Bisphosphonates for osteoporosis in people with cystic fibrosis, Cochrane Database Syst Rev, vol.3, p.2010, 2014. ,
Bench to bedside: elucidation of the OPG???RANK???RANKL pathway and the development of denosumab, Nature Reviews Drug Discovery, vol.46, issue.5, pp.401-419, 2012. ,
DOI : 10.1038/nrd3705
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial, Arthritis & Rheumatism, vol.27, issue.5, pp.1299-1309, 2008. ,
DOI : 10.1002/art.23417
Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis, Current Opinion in Chemical Biology, vol.17, issue.3, pp.353-360, 2013. ,
DOI : 10.1016/j.cbpa.2013.04.020